戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1    In this first-in-human study, up to 10 cycles of AMG 420 were given (4-week infusions/6-week cycles).
2                                      Patients in part A and were given nivolumab 3 mg/kg intravenously over 60 min on day
3 onkeys received a primary intranasal infection with RSV and were given a boost with RSV or a parainfluenza virus (PIV) ve
4                  Of 807 participants who underwent RYGB and were given an activity monitor, 649 (80%) had sufficient data
5                                          Patients in part B were given the recommended phase 2 dose.
6                                                    Chickens were given Lactobacillus casei over-expressing myosin-cross-r
7 ted activity coefficients derived from time-activity curves were given as input to OLINDA/EXM for dose calculations.
8 with myeloid-specific disruption of Lacc1 (Lacc1(Deltamye)) were given oral Salmonella Typhimurium or dextran sodium sulf
9                                                   All drugs were given intravenously; brentuximab vedotin and nivolumab w
10                                             All study drugs were given intravenously, every 3 weeks.
11  hospital admission also increased significantly when drugs were given intravenously but not intraosseously, and favored
12                                      Ovariectomized females were given daily injections to approximate hormone levels dur
13                                          The combined group were given both sildenafil and NTG treatments.
14 ritonavir-boosted darunavir (n=384), and 383 in both groups were given at least one dose of their allocated treatment.
15                 Leukemia inhibitory factor (LIF) injections were given intraperitoneally and implantation sites visualize
16 nstillation of topical antisepsis and 10 minutes after IVIs were given.
17 Ib, pembrolizumab (200 mg) and bevacizumab (10 or 15 mg/kg) were given intravenously every 3 weeks.
18                                                        Mice were given hydrodynamic tail vein injections of clustered reg
19                                                        Mice were given rectal enemas containing GDNF or saline (control)
20                                                        Mice were given tamoxifen to induce Cre recombinase.
21                                                C57BL/6 mice were given intraperitoneal injections of high-dose tamoxifen
22                                           Male C57BL/6 mice were given intraperitoneal injections of IL1B and intestinal
23 taneously injected into Cdh11(+/+) (C57BL/6J) mice and mice were given injections of antibody against CDH11, gemcitabine,
24 otopic tumors were grown from K8484 cells in mice, and mice were given injections of neutralizing antibodies against chem
25 implanted into interscapular fat pads of NSG mice, and mice were given injections of penfluridol daily for 28 days.
26                                              Germ-free mice were given drinking water with TLR2 agonist or without (contr
27                                               Juvenile mice were given partial brain irradiation of 10 or 30 Gy integral
28                                                   Some mice were given a blocking antibody against TLR2 or a TLR4 inhibit
29                                                   Some mice were given cerulean to induce pancreatitis.
30  and intestinal recycling perfusion was measured; some mice were given dextran sodium sulfate to induce colitis and/or ga
31                                                   Some mice were given injections of PD1 antibody or gemcitabine and surv
32  cells were injected into livers of C57BL/6 mice; some mice were given intraperitoneal injections of antibodies against P
33 were given intravenously; brentuximab vedotin and nivolumab were given every 3 weeks, ipilimumab was given every 6 weeks
34  Additionally, these changes were not observed when opioids were given after the traumatic event.
35 rbonyl-1,4-dihydrocollidine to induce cholestatic injury or were given carbon tetrachloride to induce liver fibrosis.
36                                                Participants were given either dexmedetomidine infusion or saline placebo
37                                                    Patients were given either oral eplerenone (25 mg/day for 1 week, incr
38                               In part 2 of GEN501, patients were given intravenous daratumumab 16 mg/kg once per week for
39 n period, family members enrolled in the intervention phase were given an informational booklet outlining opportunities f
40              Intramuscular injections of Triplex or placebo were given on days 28 and 56 after HCT.
41       Outcomes were compared from the time exception points were given, which we defined as conditional waitlist outcomes
42                                      Twenty one Wistar rats were given omeprazole orally or intravenously for 30 days, an
43                          The suPAR-overexpressing mice that were given contrast material had greater functional and histo
44 y but later progression on aromatase inhibitor (AI) therapy were given vorinostat (400 mg daily) sequentially or simultan
45 aemophilus influenza type b-hepatitis B combination vaccine were given at 2, 3, and 4 months after birth followed by a bo
46 old change of 0.64 [95% CI 0.39 to 0.89]; p=0.0002) and who were given placebo (0.62 [0.34 to 0.91]; p=0.0001).
47                                 By day 42, participants who were given the adjuvanted vaccine had a significant increase
48        We included mechanically ventilated ICU patients who were given moderate-to-high doses of opioids and expected to
49                                            All patients who were given selinexor were included in the safety analysis.
50 determined to be refugees or parolees in Cuba and those who were given parole status after arrival.